InMed Pharmaceuticals INM
NASDAQ INM
$1.34 -0.01 (-0.74%)
As of: Oct 2, 2026 · 10:04 AM EDT

InMed Pharmaceuticals (INM) Return on Assets [ROA] (2022 - 2026)

Updated

InMed Pharmaceuticals (INM) posted Return on Assets [ROA] of -206.53% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 140.86 percentage points from -65.67% a year earlier and down 122.79 percentage points from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Return on Assets [ROA] (2022 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), InMed Pharmaceuticals' Return on Assets [ROA] came in at -134.99%, down 75.42 percentage points from FY2025.

  • Annual Return on Assets [ROA] has declined for three consecutive fiscal years, though with a four-year change of +29.84 percentage points (FY2022 to FY2026).
  • In prior fiscal years, InMed Pharmaceuticals' Return on Assets [ROA] was -59.57% in FY2025 (-0.37 pp), -59.20% in FY2024 (-0.10 pp), -59.10% in FY2023 (+105.73 pp) and -164.83% in FY2022.
  • The fiscal Q4 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2022.
  • On a year-over-year basis, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of -25.23 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was fiscal Q1 2024, with a gain of 84.15 percentage points; the weakest was fiscal Q4 2026, with a drop of 140.86 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior fiscal quarters was -83.74% (Q3 2026), -62.43% (Q2 2026) and -56.74% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Linde 218.80 Bn 201.92 Bn 4.43 Bn 8.44%
2 Corning 132.43 Bn 125.56 Bn 1.63 Bn 6.46%
3 Sherwin Williams 78.49 Bn 77.53 Bn 3.34 Bn 10.08%
4 Air Products & Chemicals 61.97 Bn 59.87 Bn 1.04 Bn 0.01%
5 Corteva 51.82 Bn 40.62 Bn 3.66 Bn 2.42%
6 LyondellBasell Industries 37.12 Bn 26.74 Bn 2.04 Bn -0.99%
7 Nutrien 33.86 Bn 30.73 Bn 3.25 Bn 4.48%
8 Qnity Electronics 26.31 Bn 23.73 Bn 666.00 Mn 4.44%
9 Ati 25.78 Bn 23.93 Bn 309.80 Mn 8.91%
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - -206.53%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -206.53%
Mar 31, 2026 -83.74%
Dec 31, 2025 -62.43%
Sep 30, 2025 -56.74%
Jun 30, 2025 -65.67%
Mar 31, 2025 -93.40%
Dec 31, 2024 -83.37%
Sep 30, 2024 -61.10%
Jun 30, 2024 -60.91%
Mar 31, 2024 -42.46%
Dec 31, 2023 -48.51%
Sep 30, 2023 -55.69%
Jun 30, 2023 -55.08%
Mar 31, 2023 -97.79%
Dec 31, 2022 -107.63%
Sep 30, 2022 -139.84%
Jun 30, 2022 -131.57%
API Access

InMed Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INM&period=max&api_key=YOUR_API_KEY